Ye H, Sun M, Huang S, Xu F, Wang J, Liu H
Int J Gen Med. 2021; 14:9333-9347.
PMID: 34898998
PMC: 8654693.
DOI: 10.2147/IJGM.S336729.
Jose J
J Pharm Bioallied Sci. 2016; 8(1):23-8.
PMID: 26957864
PMC: 4766774.
DOI: 10.4103/0975-7406.171699.
Monroe A, Fu W, Zikusoka M, Jacobson L, Witt M, Palella F
AIDS Res Hum Retroviruses. 2015; 31(6):593-602.
PMID: 25664922
PMC: 4458749.
DOI: 10.1089/AID.2014.0126.
Kumar G, Srivastava A, Sharma S, Gupta Y
Ayu. 2013; 33(2):197-201.
PMID: 23559790
PMC: 3611635.
DOI: 10.4103/0974-8520.105238.
Vere C, Streba C, Streba L, Rogoveanu I
Hepat Mon. 2012; 12(6):369-71.
PMID: 22879825
PMC: 3412552.
DOI: 10.5812/hepatmon.5998.
Is statin therapy safe in patients with HIV/hepatitis C coinfection?.
Stroup J, Harris B
Proc (Bayl Univ Med Cent). 2010; 23(2):111-3.
PMID: 20396416
PMC: 2848083.
DOI: 10.1080/08998280.2010.11928595.
Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma.
Calderon R, Cubeddu L, Goldberg R, Schiff E
Mayo Clin Proc. 2010; 85(4):349-56.
PMID: 20360293
PMC: 2848423.
DOI: 10.4065/mcp.2009.0365.
Statin therapy and serum transaminases among a cohort of HCV-infected veterans.
Henderson L, Patel S, Giordano T, Green L, El-Serag H
Dig Dis Sci. 2009; 55(1):190-5.
PMID: 19731022
PMC: 3698853.
DOI: 10.1007/s10620-009-0959-1.
Use of statins in patients with liver disease.
Tandra S, Vuppalanchi R
Curr Treat Options Cardiovasc Med. 2009; 11(4):272-8.
PMID: 19627660
DOI: 10.1007/s11936-009-0028-2.
Effect of calcium lactate supplementation on cholesterol concentration in patients with hyperlipidaemia and previous viral hepatitis: a preliminary report.
Andryskowski G, Chojnowska-Jezierska J, Broncel M, Barylski M, Banach M
Cardiovasc J Afr. 2008; 19(2):84-7.
PMID: 18516353
PMC: 3975216.
Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis.
Stanca C, Bach N, Allina J, Bodian C, Bodenheimer Jr H, Odin J
Dig Dis Sci. 2008; 53(7):1988-93.
PMID: 18392679
DOI: 10.1007/s10620-007-0003-2.
Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.
McPherson R, Frohlich J, Fodor G, Genest J, Canadian Cardiovascular Society
Can J Cardiol. 2006; 22(11):913-27.
PMID: 16971976
PMC: 2570238.
DOI: 10.1016/s0828-282x(06)70310-5.